• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Georgetown University Medical Center selects Nora Volkow for Highest Honor

Bioengineer by Bioengineer
November 13, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: National Institute on Drug Abuse (NIDA)

WASHINGTON (November 13, 2018) — Georgetown University Medical Center (GUMC) will present Nora Volkow, MD, director of the National Institute on Drug Abuse, a part of the National Institutes of Health, with its highest honor, the Cura Personalis Award, at a ceremony on Tuesday, Nov. 13 at 4:00 p.m.

"The tradition of bestowing of the Cura Personalis Award is a highlight of our annual GUMC Convocation as we recognize a health professional who has made outstanding contributions to human health guided by compassion and service," says Edward B. Healton, MD, MPH, Executive Vice President for Health Sciences at Georgetown University.

The Catholic, Jesuit principle of cura personalis means care of the whole person. It suggests individualized attention to the needs of others, distinct respect for unique circumstances and concerns, and an appropriate appreciation for singular gifts and insights.

"This is our founding principle and one that has been embraced by Dr. Volkow-demonstrated through her professional role as an institute director and through her addiction research," Healton adds.

For more than 15 years, Volkow has led the NIDA's research effort to address the health aspects of drug abuse and addiction. Volkow's own work has been instrumental in demonstrating that drug addiction is a disease of the human brain. As a research psychiatrist and scientist, Volkow pioneered the use of brain imaging to investigate the toxic effects and addictive properties of abusable drugs. Her studies have documented changes in the dopamine system affecting, among others, the functions of frontal brain regions involved with motivation, drive, and pleasure in addiction. She has also made important contributions to the neurobiology of obesity, ADHD, and aging.

Volkow earned her medical degree from the National University of Mexico in Mexico City. Her completed her psychiatric residency with distinction at New York University. Before assuming her responsibilities at NIDA, she spent most of her professional career at the Department of Energy's Brookhaven National Laboratory in New York, where she held several leadership positions including Director of Nuclear Medicine, Chairman of the Medical Department, and Associate Director for Life Sciences. In addition, Volkow was a Professor in the Department of Psychiatry and Associate Dean of the Medical School at the State University of New York-Stony Brook.

Volkow is a member of the National Academy of Sciences. She has received the International Prize from the French Institute of Health and Medical Research for her pioneering work in brain imaging and addiction science, and was awarded the Carnegie Prize in Mind and Brain Sciences from Carnegie Mellon University.

###

Volkow will receive the Cura Personalis medal during the 11th Annual GUMC Convocation on Tuesday, Nov. 13th during the awards ceremony which begins at 4:00 p.m. Earlier in the day, beginning at 10:00 a.m., Volkow will join the Convocation Colloquium to explore issues of addiction and the opioid crisis.

Both activities are held in the Research Building auditorium on the GUMC campus.

About Georgetown University Medical Center

Georgetown University Medical Center (GUMC) is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC's mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis — or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization, which accounts for the majority of externally funded research at GUMC including a Clinical and Translational Science Award from the National Institutes of Health. Connect with GUMC on Facebook (Facebook.com/GUMCUpdate), Twitter (@gumedcenter) and Instagram (@GeorgetownMedicine).

Media Contact

Karen Teber
[email protected]
@Gumedcenter

Home Page

Share12Tweet8Share2ShareShareShare2

Related Posts

Mobile Health Boosts Clinic Attendance for HIV Patients

October 13, 2025

Discover Mutactimycins H-J: Antimycobacterial Treasures Uncovered!

October 13, 2025

New Lung-on-a-Chip Model Simulates Severe Influenza

October 13, 2025

20% Fertilizer Cut Inadequate for EU Green Deal

October 13, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1234 shares
    Share 493 Tweet 308
  • New Study Reveals the Science Behind Exercise and Weight Loss

    104 shares
    Share 42 Tweet 26
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    101 shares
    Share 40 Tweet 25
  • Revolutionizing Optimization: Deep Learning for Complex Systems

    91 shares
    Share 36 Tweet 23

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionizing Signal Processing: The Traveling-Wave Amplifier

Mobile Health Boosts Clinic Attendance for HIV Patients

Discover Mutactimycins H-J: Antimycobacterial Treasures Uncovered!

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 64 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.